Course and Predictive Factors of Incomplete Response to Therapy in Low- and Intermediate-Risk Thyroid Cancer.

Alzahrani, Ali S; Moria, Yosra; Mukhtar, Noha; Aljamei, Hadeel; Mazi, Sedra; Albalawi, Lina; Aljomaiah, Abeer

Alzahrani, Ali S; Moria, Yosra; Mukhtar, Noha; Aljamei, Hadeel; Mazi, Sedra; Albalawi, Lina; Aljomaiah, Abeer.

Afiliação

Alzahrani AS; Department of Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Moria Y; Department of Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Mukhtar N; Department of Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Aljamei H; Department of Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Mazi S; Department of Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Albalawi L; Department of Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Aljomaiah A; Department of Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.

J Endocr Soc ; 5(1): bvaa178, 2021 Jan 01.

Article em En | MEDLINE | ID: mdl-33367194

Palavras-chave

American Thyroid Association; differentiated thyroid cancer; response to therapy; risk stratification; thyroid cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google